1. Home
  2. SPRY vs GIBO Comparison

SPRY vs GIBO Comparison

Compare SPRY & GIBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • GIBO
  • Stock Information
  • Founded
  • SPRY 2015
  • GIBO 2019
  • Country
  • SPRY United States
  • GIBO Hong Kong
  • Employees
  • SPRY N/A
  • GIBO N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • GIBO
  • Sector
  • SPRY Health Care
  • GIBO
  • Exchange
  • SPRY Nasdaq
  • GIBO NYSE
  • Market Cap
  • SPRY 1.6B
  • GIBO 1.4B
  • IPO Year
  • SPRY N/A
  • GIBO N/A
  • Fundamental
  • Price
  • SPRY $17.69
  • GIBO $0.04
  • Analyst Decision
  • SPRY Strong Buy
  • GIBO
  • Analyst Count
  • SPRY 4
  • GIBO 0
  • Target Price
  • SPRY $28.75
  • GIBO N/A
  • AVG Volume (30 Days)
  • SPRY 1.6M
  • GIBO 99.0M
  • Earning Date
  • SPRY 08-05-2025
  • GIBO 01-01-0001
  • Dividend Yield
  • SPRY N/A
  • GIBO N/A
  • EPS Growth
  • SPRY N/A
  • GIBO N/A
  • EPS
  • SPRY N/A
  • GIBO N/A
  • Revenue
  • SPRY $97,122,000.00
  • GIBO N/A
  • Revenue This Year
  • SPRY N/A
  • GIBO N/A
  • Revenue Next Year
  • SPRY $170.64
  • GIBO N/A
  • P/E Ratio
  • SPRY N/A
  • GIBO N/A
  • Revenue Growth
  • SPRY 971120.00
  • GIBO N/A
  • 52 Week Low
  • SPRY $8.91
  • GIBO $0.03
  • 52 Week High
  • SPRY $18.90
  • GIBO $11.18
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.97
  • GIBO N/A
  • Support Level
  • SPRY $16.40
  • GIBO N/A
  • Resistance Level
  • SPRY $18.05
  • GIBO N/A
  • Average True Range (ATR)
  • SPRY 1.06
  • GIBO 0.00
  • MACD
  • SPRY 0.03
  • GIBO 0.00
  • Stochastic Oscillator
  • SPRY 62.54
  • GIBO 0.00

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About GIBO GIBO HOLDINGS LIMITED

GIBO Holdings Ltd, along with its subsidiaries is focused on revolutionizing content creation and consumption through AI. The company acts as a integrated AIGC animation streaming platform with extensive functionalities provided to both viewers and creators that serves a broad community of young people across Asia to create, publish, share and enjoy AI-generated animation video content.

Share on Social Networks: